Project Watson Dog Eyelid Wipes Recalled By Bausch + Lomb Due To Bacteria, Fungi Risks

Federal safety officials have announced a recall of Project Watson Eyelid Wipes for Dogs due to potential contamination with dangerous bacteria and fungi, which can create an infection risk for humans.

The Consumer Product and Safety Commission (CPSC) issued the Project Watson Dog Eyelid Wipes recall on May 2, after the company received several reports of the containers developing a film-like substance after they had been opened and used.

Bacteria and fungi, commonly found in soil and water, can enter the wipe container when it has been opened and in use and grow, infecting people with opened wounds or weakened immune systems who handle the wipes or container, which could result in serious health risks, the recall warns.

To date, the CPSC reports that there have been no injuries or illnesses of humans or pets.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The recall affects an estimated 32,000 Project Watson Eyelid Wipes (45 count) for dogs. which are sold in a small round container with a twist-on lid and blue and white labeling. “PROJECT WATSON” and “BAUSCH + LOMB” are printed on the label. The affected containers have one of two lot numbers, A09050 or A10055, printed on the bottom.

These products were available for purchase nationwide at retailers such as PetSmart, Walmart, and others, as well as online through Chewy.com and Amazon.com, from February 2023 to March 2024, and cost between $13 and $15.

The CPSC advises consumers to immediately stop using this product and request a full refund using a picture of the recalled product online at http://eyelidwiperecall.com. Consumers should then throw away the wipes in any household garbage can.

For additional details, customers can contact Project Watson at 877-857-1149 between 8:30 a.m. and 5 p.m. ET, Monday through Friday, or visit their official website.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.
Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.